Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $197.70 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $38.81 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $35.57 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.14 | 1 | $0 (2022) |
| AbbVie Inc. | $27.57 | 1 | $0 (2023) |
| TESARO, Inc. | $26.14 | 1 | $0 (2018) |
| GENZYME CORPORATION | $21.44 | 1 | $0 (2024) |
| Celgene Corporation | $16.03 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.44 | 1 | GENZYME CORPORATION ($21.44) |
| 2023 | $27.57 | 1 | AbbVie Inc. ($27.57) |
| 2022 | $67.71 | 3 | Merck Sharp & Dohme LLC ($35.57) |
| 2019 | $38.81 | 1 | Novo Nordisk Inc ($38.81) |
| 2018 | $42.17 | 2 | TESARO, Inc. ($26.14) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2024 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Genetic Disease | ||||||
| 04/25/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/22/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | CUVITRU (Biological) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: IMMUNOLOGY | ||||||
| 06/29/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $38.81 | General |
| 10/09/2018 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Hematology / Oncology | ||||||
| 10/05/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 3,156 | 10,108 | $576,335 | $169,091 |
| 2022 | 49 | 3,626 | 12,496 | $636,694 | $195,179 |
| 2021 | 51 | 3,384 | 11,566 | $507,892 | $175,488 |
| 2020 | 49 | 3,562 | 14,584 | $568,580 | $222,334 |
All Medicare Procedures & Services
267 procedure records from CMS Medicare Utilization — Page 1 of 11
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 285 | 285 | $89,205 | $35,517 | 39.8% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 284 | 284 | $35,784 | $14,667 | 41.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 71 | 71 | $43,523 | $12,357 | 28.4% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 53 | 53 | $25,440 | $6,934 | 27.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 29 | 29 | $22,968 | $6,778 | 29.5% |
| 71271 | Low dose ct scan of chest for lung cancer screening | Office | 2023 | 46 | 46 | $16,054 | $6,409 | 39.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 249 | 264 | $20,856 | $5,913 | 28.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 44 | 44 | $20,768 | $5,785 | 27.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 135 | 135 | $12,150 | $5,140 | 42.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 51 | 52 | $15,223 | $4,698 | 30.9% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 144 | 151 | $21,442 | $4,393 | 20.5% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 16 | 16 | $13,673 | $4,224 | 30.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 53 | 53 | $13,620 | $3,941 | 28.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 47 | 48 | $13,256 | $3,727 | 28.1% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 33 | 34 | $11,458 | $3,643 | 31.8% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 68 | 71 | $12,709 | $2,603 | 20.5% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Facility | 2023 | 40 | 41 | $12,587 | $2,570 | 20.4% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 296 | 330 | $10,890 | $2,199 | 20.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 30 | 30 | $7,626 | $2,015 | 26.4% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 14 | 14 | $6,454 | $1,980 | 30.7% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 53 | 63 | $6,867 | $1,900 | 27.7% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Facility | 2023 | 29 | 29 | $8,497 | $1,817 | 21.4% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 18 | 18 | $7,722 | $1,771 | 22.9% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 39 | 40 | $8,320 | $1,675 | 20.1% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 50 | 50 | $6,050 | $1,666 | 27.5% |
About Dr. Carole Roseland, DO
Dr. Carole Roseland, DO is a Diagnostic Radiology healthcare provider based in Southfield, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033132576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carole Roseland, DO has received a total of $197.70 in payments from pharmaceutical and medical device companies, with $21.44 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($197.70).
As a Medicare-enrolled provider, Roseland has provided services to 13,728 Medicare beneficiaries, totaling 48,754 services with total Medicare billing of $762,093. Data is available for 4 years (2020–2023), covering 267 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Nuclear Radiology
- Location Southfield, MI
- Active Since 07/25/2006
- Last Updated 05/15/2018
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1033132576
Products in Payments
- CUVITRU (Biological) $32.14
- TEFLARO (Drug) $27.57
- ZEJULA (Drug) $26.14
- FABRAZYME (Biological) $21.44
- DIFICID (Drug) $18.29
- VERQUVO (Drug) $17.28
- Revlimid (Drug) $16.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Southfield
Ashok Jain, Md, MD
Diagnostic Radiology — Payments: $763.79
Dr. Rani Bashiti
Diagnostic Radiology — Payments: $138.85
Victoria Swegles, Do, DO
Diagnostic Radiology — Payments: $125.31
Carl Collins
Diagnostic Radiology — Payments: $108.39
Michael Butterfield, M.d, M.D
Diagnostic Radiology — Payments: $78.58
Dr. Brett Arnkoff, M.d, M.D
Diagnostic Radiology — Payments: $70.31